DMT-induced shifts in criticality correlate with self-dissolution
DMT shifts brain oscillatory dynamics away from criticality—towards subcritical regimes—in alpha and adjacent (theta) bands, increasing entropy and reducing complexity. These shifts, quantified via a functional excitatory–inhibitory ratio, correlate with the intensity of subjective self‑dissolution.
Authors
- Irrmischer, M.
- Aqil, M.
- Luan, L.
Published
Abstract
Psychedelics profoundly alter subjective experience and brain dynamics. Brain oscillations express signatures of near-critical dynamics, relevant for healthy function. Alterations in the proximity to criticality have been suggested to underlie the experiential and neurological effects of psychedelics. Here, we investigate the effects of a psychedelic substance (DMT) on the criticality of brain oscillations, and in relation to subjective experience, in humans of either sex. We find that DMT shifts the dynamics of brain oscillations away from criticality in alpha and adjacent frequency bands. In this context, entropy is increased while complexity is reduced. We find that the criticality-shifts observed in alpha and theta bands correlate with the intensity ratings of self-dissolution, a hallmark of psychedelic experience. Finally, using a recently developed metric, the functional excitatory-inhibitory ratio, we find that the DMT-induced criticality-shift in brain oscillations is toward subcritical regimes. These findings have major implications for the neuronal understanding of the self and psychedelics, as well as for the neurological basis of altered states of consciousness.
Research Summary of 'DMT-induced shifts in criticality correlate with self-dissolution'
Introduction
The authors frame their study within recent interest in how classic psychedelics alter subjective experience and brain dynamics. They explain the concept of criticality — a dynamical regime in which correlations persist over long distances and timescales, producing scale-invariant, complex fluctuations — and note that the human brain is often thought to operate near criticality. Long-range temporal correlations (LRTCs) in oscillatory amplitude envelopes are presented as an empirical signature of proximity to criticality, and detrended fluctuation analysis (DFA) is introduced as a method for quantifying LRTCs. The introduction also notes that DFA alone cannot distinguish shifts toward inhibition-dominated (subcritical) versus excitation-dominated (supercritical) regimes, and that a recently developed functional excitatory/inhibitory (fE/I) ratio can provide directional information. This study set out to quantify markers of criticality in human EEG recordings under the influence of the short-acting psychedelic DMT, and to relate those markers to subjective reports of self-dissolution (measured with a specific visual analogue scale item). M. and colleagues combined two placebo-controlled, single-blind, within-participant EEG datasets to test whether DMT alters DFA-estimated LRTCs and fE/I, whether those changes indicate sub- or supercritical shifts, and whether such changes correlate with disruption of self-related processing during the psychedelic state. The authors emphasise that linking criticality metrics with subjective self-dissolution could provide novel neural correlates of self-related processing in altered states of consciousness.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Topic
- APA Citation
Irrmischer, M., Aqil, M., Luan, L., Wang, T., Engelbregt, H., Carhart-Harris, R., Linkenkaer-Hansen, K., & Timmermann, C. (2026). DMT-induced shifts in criticality correlate with self-dissolution. The Journal of Neuroscience, 46(2), e0344252025. https://doi.org/10.1523/jneurosci.0344-25.2025
References (17)
Papers cited by this study that are also in Blossom
Aqil, M., Roseman, L. · Neuropharmacology (2022)
Carhart-Harris, R. L. · Neuropharmacology (2018)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
van Elk, M., Yaden, D. B. · Neuroscience and Biobehavioral Reviews (2022)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Halberstadt, A. L. · Behavioural Brain Research (2014)
Inserra, A., De Gregorio, D., Gobbi, G. · Pharmacological Reviews (2021)
Kałużna, A., Schlosser, M., Gulliksen Craste, E. et al. · Journal of Psychedelic Studies (2022)
Kwan, A. C., Olson, D. E., Preller, K. H. et al. · Nature Medicine (2022)
Show all 17 referencesShow fewer
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R. et al. · Trends in Pharmacological Sciences (2017)
Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)
Schartner, M., Carhart-Harris, R. L., Barrett, A. B. et al. · Scientific Reports (2017)
Timmermann, C., Vollenweider, F. X. · Trends in Cognitive Sciences (2023)
Timmermann, C., Roseman, L., Haridas, S. et al. · PNAS (2023)
Timmermann, C., Roseman, L., Schartner, M. et al. · Scientific Reports (2019)
Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.